source of money, especially given current mortgage rates. Also,
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
_new" href="http://www.directlendingsolutions.com/mortgageinterest.htm">int
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
rest paid on home-equity debt is normally tax-deductible, making the ef
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
fective interest rate even lower. The overall cost of a heloc is going to b
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
less than most credit cards you have access to.
You need to be discipline
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
, however. There is one very real danger of using home equity loans for pur
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
hases. Keep in mind that credit cards are unsecured, while a heloc or home
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
equity loan is secured. Your home is the collateral. It is vital that you <
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
a target="_new" href="http://www.directlendingsolutions.com">plan ahead
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
and know for certain that this type of loan is best for you. You must be c
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
rtain that you can make the monthly payments in addition to your normal mor
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
gage payments. Defaulting could definitely mean foreclosure on your home.
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
Don't make this the most expensive holiday season ever by losing your home
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
because of a defaulted home equity loan. If you do not feel that you will
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ave the ability to make the payments, on time, each month, we recommend tha
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
you consider other funding sources. Some of these sources include credit
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
ards and even friends and family, Spend wisely and enjoy the holiday season
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
